tiprankstipranks
Trending News
More News >
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
US Market

Syndax Pharmaceuticals (SNDX) Income Statement

Compare
896 Followers

Syndax Pharmaceuticals Income Statement

Last quarter (Q3 2025), Syndax Pharmaceuticals's total revenue was $45.87M, an increase of 266.97% from the same quarter last year. In Q3, Syndax Pharmaceuticals's net income was $-60.72M. See Syndax Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 23.68M$ 0.00$ 0.00$ 139.71M$ 1.52M
Gross Profit
$ 22.85M$ 0.00$ 0.00$ 139.71M$ 1.52M
Operating Expenses
$ 362.53M$ 229.95M$ 151.76M$ 113.49M$ 72.94M
Depreciation and Amortization
$ 8.00K$ 12.00K$ 33.00K$ 43.00K$ 515.00K
EBITDA
$ -313.82M$ -209.14M$ -146.17M$ 26.87M$ -70.29M
Operating Income
$ -339.67M$ -229.95M$ -151.76M$ 26.22M$ -71.42M
Other Income/Expenses
$ 20.91M$ 20.59M$ 2.42M$ -1.29M$ -1.74M
Pretax Income
$ -318.76M$ -209.36M$ -149.34M$ 24.93M$ -73.16M
Net Income
$ -318.76M$ -209.36M$ -149.34M$ 24.93M$ -73.07M
Per Share Metrics
Basic EPS
$ -3.73$ -2.98$ -2.46$ 0.48$ -1.77
Diluted EPS
$ -3.73$ -2.98$ -2.46$ 0.48$ -1.77
Weighted Average Shares Outstanding
85.62M 70.37M 60.76M 52.06M 41.31M
Weighted Average Shares Outstanding (Diluted)
85.62M 70.37M 60.76M 52.06M 41.31M
Currency in USD

Syndax Pharmaceuticals Earnings and Revenue History